Skip to main content
. 2013 Jul 8;14(4):3–13. doi: 10.1120/jacmp.v14i4.4065

Table 2.

Summary of dosimetric comparison expressed in mean values ± standard deviation. Significance is indicated by p<0.05. Only D2cm and Rib Dmax were significant for RA vs. FF IMRT

IMRT RA HT P‐value RA vs. HT P‐value FF IMRT vs. HT
Target (PTV)
CI100%
1.36±2.9
1.29±2.2
1.06±0.03
<0.05
<0.05
R50%
7.1±1.9
6.53±1.2
5.3±0.9
<0.01
<0.01
D2cm(%)
75.65±12.7
67.34±10.5
51.89±16.3
<0.01
<0.01
HI
1.15±0.02
1.14±0.02
1.07±0.02
<0.01
<0.01
Maximum Dose (%)
118.26±2.3
117.51±1.0
110.26±2.9
<0.01
<0.01
OAR (Gy)
Spinal Cord
13.9±9.7
14.25±7.7
13.08±5.6
0.22 0.22
Esophagus
11.62±5.7
14.12±6.5
13.71±6.3
0.54 0.51
Heart
10.93±12.2
9.72±11.9
8.59±10.3
0.12 0.06
Trachea
11.32±8.3
11.86±8.3
11.66±6.9
0.81 0.77
Rib Dmax
49.53±10.5
47.04±12.9
42.54±12.1
<0.01
<0.01
Lung V20(%)
6.6±3.7
6.32±3.9
5.81±3.4
0.11 0.12